Which of the following must be included in a CSP’s label?

The correct response highlights the essential components that must be included on the label of a Compounded Sterile Preparation (CSP) to ensure safety, accuracy, and compliance with regulatory standards. The drug name and concentrations are critical for the identification of the product and to ensure that the correct medication is provided to the patient. The Beyond-Use Date (BUD) is crucial for ensuring that the CSP is used within the timeframe in which it is still safe and effective. Additionally, storage conditions inform the pharmacist and caregiver on how to maintain the stability of the preparation, which helps prevent degradation or microbial contamination. Lastly, including patient information on the label facilitates proper administration and monitoring, ensuring that the CSP is correctly matched to the intended recipient.

In contrast, other answer choices lack comprehensive information. The second answer mentions only the manufacturing and expiration dates, which do not provide adequate details for safe use and administration of the CSP. The third response focuses on the compounding technician's name and method of preparation, which, while important for accountability and reproducibility, do not encompass the critical information necessary for the end-user or healthcare provider. Lastly, the fourth option includes the pharmacy's contact information and emergency procedures, which are beneficial but not mandatory items on a CSP label compared